PARIS & NEW YORK--(EON: Enhanced Online News)--IOMA, a revolutionary and innovative evidence based skincare concept from France, pioneered by technology visionary Jean Michel Karam PhD, also founder and Chairman of MEMSCAP (NYSE Euronext: MEMS), debuts today in USA at Saks Fifth Avenue, New York.
“IOMA’s evidence-based approach to skincare diagnoses complexion imperfections, constructs customized regimens for care of the skin, and measures and quantifies the effectiveness of its protocols. We believe that IOMA is truly changing the boundaries and setting new foundations for a new skincare era.”
Unprecedented, in the beauty industry, IOMA applies the most advanced imaging and probe-based techniques, powered by MEMS (Micro Electro Mechanical Systems) technology, combined with targeted and customized skincare regimens, for an entirely customizable treatment program with quantifiable, optimized results.
"IOMA is a game-changer for the skincare industry,” says Dr. Karam. “IOMA’s evidence-based approach to skincare diagnoses complexion imperfections, constructs customized regimens for care of the skin, and measures and quantifies the effectiveness of its protocols. We believe that IOMA is truly changing the boundaries and setting new foundations for a new skincare era.”
A breakthrough in skincare, IOMA uses MEMS-based technology to analyze skin below the surface, and prescribe a completely customized skincare regimen in a way never possible before. An entirely holistic and integrated approach to skincare, the IOMA devices will also be able to track and measure results over time, truly earning the moniker “Evidence Based Skincare.”
MEMS Technology has been previously used in a variety of applications and market segments, such as automotive, aeronautics, telecommunications, medical and biomedical as well as very recently in the consumer goods electronic sectors.
IOMA will continue to announce additional news and expanded distribution in the coming weeks.
For more information regarding IOMA please contact MediaCraft, 212.206.9192 or at email@example.com
MEMSCAP is the leading provider of innovative micro-electro-mechanical systems (MEMS)-based solutions. MEMSCAP standard and custom products and solutions include components, component devices (IP), manufacturing and related services. MEMSCAP customers include Fortune 500 businesses, major research institutes and universities. The company’s shares are traded on the Eurolist of NYSE Euronext Paris S.A. (ISIN: FR00010298620-MEMS), and belong to the CAC small, CAC Mid & Small, CAC All-Tradable and CAC All-Share indexes. More information on the company’s products and services can be obtained at www.memscap.com.
IntuiSkin is a spin-off from the MEMSCAP group. It is the provider of innovative skin dedicated systems, products and services. Leveraging on the group expertise, experience, vast patent portfolio and years of research dedicated by its team, as well as on the validation of its products by renowned names in science and cosmetics, it has developed and created a unique technology that puts science at the service of your skin. IntuiSkin provides each skin with tomorrow’s products in order to cater for its specific needs. In 2008, IntuiSkin developed and successfully launched IOMA, a truly global and innovative concept, designed to treat, improve and preserve the quality of the skin.
SAKS FIFTH AVENUE
Saks Fifth Avenue, one of the world’s preeminent specialty retailers, is renowned for its superlative American and international designer collections, its expertly edited assortment of handbags, shoes, jewelry, cosmetics and gifts, and the first-rate fashion expertise and exemplary client service of its Associates. Today, Saks operates 46 full-line stores in 22 states, 5 licensed stores in the Middle East and 2 licensed stores in Mexico City, 57 Saks Fifth Avenue OFF 5TH stores and saks.com the company’s online store.